REPLIMUNE GROUP, INC. Increase Decrease In Operating Lease Liability
REPLIMUNE GROUP, INC. (REPL) reported Increase Decrease In Operating Lease Liability of -$218.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-08-14
- REPLIMUNE GROUP, INC. increase decrease in operating lease liability for the quarter ending 2026-06-30 was -$218.00K.
- REPLIMUNE GROUP, INC. increase decrease in operating lease liability for the quarter ending 2026-03-31 was -$213.00K.
- REPLIMUNE GROUP, INC. increase decrease in operating lease liability for the quarter ending 2025-12-31 was -$207.00K.
- REPLIMUNE GROUP, INC. increase decrease in operating lease liability for the quarter ending 2025-09-30 was -$203.00K.
- REPLIMUNE GROUP, INC. increase decrease in operating lease liability for fiscal 2026 was -$818.00K.
- REPLIMUNE GROUP, INC. increase decrease in operating lease liability for fiscal 2025 was -$720.00K.
- REPLIMUNE GROUP, INC. increase decrease in operating lease liability for fiscal 2024 was -$620.00K.
- REPLIMUNE GROUP, INC. increase decrease in operating lease liability for fiscal 2023 was -$238.00K.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$218.00K 10-Q · filed 2026-08-14 | -$431.00K derived: sum of 2 quarters · filed 2026-08-14 | -$638.00K derived: sum of 3 quarters · filed 2026-08-14 | -$841.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | -$213.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-29 | -$420.00K derived: sum of 2 quarters · filed 2026-06-29 | -$623.00K derived: sum of 3 quarters · filed 2026-06-29 | -$818.00K 10-K · filed 2026-06-29 |
| 2025-12-31 | -$207.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-03 | -$410.00K derived: sum of 2 quarters · filed 2026-02-03 | -$605.00K 10-Q · filed 2026-02-03 | -$792.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-09-30 | -$203.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-06 | -$398.00K 10-Q · filed 2025-11-06 | -$585.00K derived: sum of 3 quarters · filed 2026-08-14 | -$768.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | -$195.00K 10-Q · filed 2026-08-14 | -$382.00K derived: sum of 2 quarters · filed 2026-08-14 | -$565.00K derived: sum of 3 quarters · filed 2026-08-14 | -$744.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | -$187.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-29 | -$370.00K derived: sum of 2 quarters · filed 2026-06-29 | -$549.00K derived: sum of 3 quarters · filed 2026-06-29 | -$720.00K 10-K · filed 2026-06-29 |
| 2024-12-31 | -$183.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-03 | -$362.00K derived: sum of 2 quarters · filed 2026-02-03 | -$533.00K 10-Q · filed 2026-02-03 | -$720.00K derived: sum of 4 quarters · filed 2026-02-03 |
| 2024-09-30 | -$179.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-06 | -$350.00K 10-Q · filed 2025-11-06 | -$537.00K derived: sum of 3 quarters · filed 2025-11-06 | -$680.00K derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | -$171.00K 10-Q · filed 2025-08-07 | -$358.00K derived: sum of 2 quarters · filed 2025-08-07 | -$501.00K derived: sum of 3 quarters · filed 2025-08-07 | -$638.00K derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | -$187.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-05-22 | -$330.00K derived: sum of 2 quarters · filed 2025-05-22 | -$467.00K derived: sum of 3 quarters · filed 2025-05-22 | -$620.00K 10-K · filed 2025-05-22 |
| 2023-12-31 | -$143.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-02-12 | -$280.00K derived: sum of 2 quarters · filed 2025-02-12 | -$433.00K 10-Q · filed 2025-02-12 | -$280.00K derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-09-30 | -$137.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-11-12 | -$290.00K 10-Q · filed 2024-11-12 | -$137.00K derived: sum of 3 quarters · filed 2024-11-12 | -$271.00K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | -$153.00K 10-Q · filed 2024-08-08 | $0.00 derived: sum of 2 quarters · filed 2024-08-08 | -$134.00K derived: sum of 3 quarters · filed 2024-08-08 | -$263.00K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $153.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-05-16 | $19.00K derived: sum of 2 quarters · filed 2024-05-16 | -$110.00K derived: sum of 3 quarters · filed 2024-05-16 | -$238.00K 10-K · filed 2024-05-16 |
| 2022-12-31 | -$134.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-02-08 | -$263.00K derived: sum of 2 quarters · filed 2024-02-08 | -$391.00K 10-Q · filed 2024-02-08 | -$512.00K derived: sum of 4 quarters · filed 2024-02-08 |
| 2022-09-30 | -$129.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-11-07 | -$257.00K 10-Q · filed 2023-11-07 | -$378.00K derived: sum of 3 quarters · filed 2023-11-07 | -$115.00K derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | -$128.00K 10-Q · filed 2023-08-03 | -$249.00K derived: sum of 2 quarters · filed 2023-08-03 | $14.00K derived: sum of 3 quarters · filed 2023-08-03 | -$95.00K derived: sum of 4 quarters · filed 2023-08-03 |
| 2022-03-31 | -$121.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-05-18 | $142.00K derived: sum of 2 quarters · filed 2023-05-18 | $33.00K derived: sum of 3 quarters · filed 2023-05-18 | -$73.00K 10-K · filed 2023-05-18 |
| 2021-12-31 | $263.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-02-09 | $154.00K derived: sum of 2 quarters · filed 2023-02-09 | $48.00K 10-Q · filed 2023-02-09 | -$55.00K derived: sum of 4 quarters · filed 2023-02-09 |
| 2021-09-30 | -$109.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-11-03 | -$215.00K 10-Q · filed 2022-11-03 | -$318.00K derived: sum of 3 quarters · filed 2022-11-03 | -$373.00K derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-06-30 | -$106.00K 10-Q · filed 2022-08-04 | -$209.00K derived: sum of 2 quarters · filed 2022-08-04 | -$264.00K derived: sum of 3 quarters · filed 2022-08-04 | -$314.00K derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | -$103.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-05-19 | -$158.00K derived: sum of 2 quarters · filed 2022-05-19 | -$208.00K derived: sum of 3 quarters · filed 2022-05-19 | -$340.00K 10-K · filed 2022-05-19 |
| 2020-12-31 | -$55.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-02-03 | -$105.00K derived: sum of 2 quarters · filed 2022-02-03 | -$237.00K 10-Q · filed 2022-02-03 | |
| 2020-09-30 | -$50.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-11-04 | -$182.00K 10-Q · filed 2021-11-04 | ||
| 2020-06-30 | -$132.00K 10-Q · filed 2021-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| MeiraGTx Holdings plc (MGTX) | United States | $1.061B | 16.10 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Maze Therapeutics, Inc. (MAZE) | United States | $1.457B | -12.40 |
| Inhibrx Biosciences, Inc. (INBX) | United States | $1.477B | -10.08 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B |